Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
27.40
+0.02 (0.05%)
Oct 19, 2026, 12:15 PM EDT - Market open
Pediatrix Medical Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,173 | 1,801 | 1,109 | 770 | 1,217 | 2,319 | |
Market Cap Growth | 51.69% | 62.37% | 43.96% | -36.73% | -47.51% | 12.69% |
Enterprise Value | 2,389 | 1,980 | 1,572 | 1,353 | 1,931 | 2,929 |
Last Close Price | 27.38 | 21.39 | 13.12 | 9.30 | 14.86 | 27.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.04 | 10.89 | - | - | 18.35 | 17.71 |
Forward PE | 11.55 | 9.92 | 8.86 | 7.40 | 8.29 | 16.25 |
PS Ratio | 1.11 | 0.94 | 0.55 | 0.39 | 0.62 | 1.21 |
PB Ratio | 2.46 | 2.08 | 1.45 | 0.91 | 1.37 | 2.59 |
P/FCF Ratio | 9.50 | 7.13 | 6.01 | 7.41 | 8.87 | 52.14 |
P/OCF Ratio | 8.80 | 6.64 | 5.37 | 5.61 | 7.29 | 30.23 |
PEG Ratio | - | 0.93 | 1.23 | 1.35 | 0.94 | 0.94 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.22 | 1.03 | 0.78 | 0.68 | 0.98 | 1.53 |
EV/EBITDA Ratio | 9.05 | 7.83 | 7.28 | 6.97 | 8.20 | 11.72 |
EV/EBIT Ratio | 9.92 | 8.57 | 8.56 | 8.57 | 9.66 | 13.45 |
EV/FCF Ratio | 10.44 | 7.84 | 8.52 | 13.01 | 14.08 | 65.83 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.70 | 0.73 | 0.87 | 0.83 | 0.80 | 1.19 |
Debt / EBITDA Ratio | 2.25 | 2.35 | 2.69 | 3.10 | 2.67 | 3.82 |
Debt / FCF Ratio | 2.71 | 2.51 | 3.59 | 6.75 | 5.23 | 23.96 |
Net Debt / Equity Ratio | 0.25 | 0.16 | 0.41 | 0.62 | 0.69 | 0.65 |
Net Debt / EBITDA Ratio | 0.82 | 0.53 | 1.45 | 2.70 | 2.61 | 2.32 |
Net Debt / FCF Ratio | 0.94 | 0.53 | 1.70 | 5.04 | 4.47 | 13.01 |
Asset Turnover | 0.92 | 0.87 | 0.92 | 0.87 | 0.78 | 0.63 |
Quick Ratio | 1.28 | 1.62 | 1.43 | 1.18 | 0.94 | 1.88 |
Current Ratio | 1.32 | 1.66 | 1.47 | 1.24 | 1.00 | 1.97 |
Return on Equity (ROE) | 20.39% | 20.28% | -12.28% | -6.94% | 7.00% | 13.13% |
Return on Assets (ROA) | 7.11% | 6.57% | 5.25% | 4.32% | 4.93% | 4.48% |
Return on Invested Capital (ROIC) | 16.34% | 16.98% | 14.98% | 10.97% | 10.32% | 12.42% |
Return on Capital Employed (ROCE) | 14.80% | 12.90% | 10.70% | 8.60% | 10.40% | 9.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.05% | 9.19% | -8.93% | -7.84% | 5.45% | 5.65% |
FCF Yield | 10.53% | 14.03% | 16.64% | 13.50% | 11.27% | 1.92% |
Buyback Yield / Dilution | 1.21% | -2.33% | -1.37% | 2.28% | 1.99% | -2.92% |